97 related articles for article (PubMed ID: 16764944)
1. Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way.
Berghmans N; Dillen C; Heremans H
J Neuroimmunol; 2006 Jul; 176(1-2):63-75. PubMed ID: 16764944
[TBL] [Abstract][Full Text] [Related]
2. Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice.
Heremans H; Dillen C; Groenen M; Matthys P; Billiau A
Eur Cytokine Netw; 1999 Jun; 10(2):171-80. PubMed ID: 10400823
[TBL] [Abstract][Full Text] [Related]
3. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma.
Heremans H; Dillen C; Groenen M; Martens E; Billiau A
Eur J Immunol; 1996 Oct; 26(10):2393-8. PubMed ID: 8898951
[TBL] [Abstract][Full Text] [Related]
4. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis.
Xiao BG; Ma CG; Xu LY; Link H; Lu CZ
Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713
[TBL] [Abstract][Full Text] [Related]
5. Early administration of IL-12 suppresses EAE through induction of interferon-gamma.
Gran B; Chu N; Zhang GX; Yu S; Li Y; Chen XH; Kamoun M; Rostami A
J Neuroimmunol; 2004 Nov; 156(1-2):123-31. PubMed ID: 15465603
[TBL] [Abstract][Full Text] [Related]
6. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis.
Constantinescu CS; Wysocka M; Hilliard B; Ventura ES; Lavi E; Trinchieri G; Rostami A
J Immunol; 1998 Nov; 161(9):5097-104. PubMed ID: 9794448
[TBL] [Abstract][Full Text] [Related]
8. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively.
Constantinescu CS; Hilliard B; Ventura E; Wysocka M; Showe L; Lavi E; Fujioka T; Scott P; Trinchieri G; Rostami A
Clin Immunol; 2001 Jan; 98(1):23-30. PubMed ID: 11141323
[TBL] [Abstract][Full Text] [Related]
9. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
Bright JJ; Du C; Coon M; Sriram S; Klaus SJ
J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12.
Leonard JP; Waldburger KE; Schaub RG; Smith T; Hewson AK; Cuzner ML; Goldman SJ
Crit Rev Immunol; 1997; 17(5-6):545-53. PubMed ID: 9419442
[TBL] [Abstract][Full Text] [Related]
11. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
12. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.
Brod SA; Khan M
J Autoimmun; 1996 Feb; 9(1):11-20. PubMed ID: 8845048
[TBL] [Abstract][Full Text] [Related]
14. Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis.
Jensen MA; Arnason BG; Toscas A; Noronha A
J Autoimmun; 1996 Oct; 9(5):587-97. PubMed ID: 8933274
[TBL] [Abstract][Full Text] [Related]
15. Effect of selective IL-6 inhibitor Am-80 on experimental autoimmune encephalomyelitis in DA rats.
Wang T; Nagai H; Bouda K; Matsuura S; Takaoka Y; Niwa S; Homma T; Tanaka H; Shudo K
Acta Pharmacol Sin; 2000 Nov; 21(11):967-76. PubMed ID: 11501064
[TBL] [Abstract][Full Text] [Related]
16. Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection.
Uyttenhove C; Arendse B; Stroobant V; Brombacher F; Van Snick J
Eur J Immunol; 2004 Dec; 34(12):3572-81. PubMed ID: 15549728
[TBL] [Abstract][Full Text] [Related]
17. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
[TBL] [Abstract][Full Text] [Related]
18. Critical role of preproenkephalin in experimental autoimmune encephalomyelitis.
Weir C; McNeill A; Hook S; Harvie M; La Flamme AC; Le Gros G; Bäckström BT
J Neuroimmunol; 2006 Oct; 179(1-2):18-25. PubMed ID: 16904193
[TBL] [Abstract][Full Text] [Related]
19. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis.
Suryani S; Sutton I
J Neuroimmunol; 2007 Feb; 183(1-2):96-103. PubMed ID: 17240458
[TBL] [Abstract][Full Text] [Related]
20. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses.
Walsh KP; Brady MT; Finlay CM; Boon L; Mills KH
J Immunol; 2009 Aug; 183(3):1577-86. PubMed ID: 19587018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
